PAXMEDICA INC (PXMD)
US70424C2035 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 16.15M | 10.61M | 7.20M | 5.56M | 600.00K | |||
| Research and Development | 3.91M | 1.79M | 2.22M | 940.00K | 480.00K | |||
| Selling, General, and Administrative Expenses | 12.23M | 8.82M | 4.97M | 4.63M | 110.00K | |||
| Operating Income | -16.15M | -10.61M | -7.20M | -5.56M | -600.00K | |||
| Interest Income/Expense | -9.17K | -10.00K | -2.81M | -610.00K | N/A | |||
| Other Income/Expense | -2.09M | -3.64M | -290.00K | -1.57M | N/A | |||
| Non Recurring Items | -45.59K | -550.00K | 60.00K | -80.00K | N/A | |||
| Income Before Taxes | -18.29M | -14.80M | -10.23M | -7.83M | -600.00K | |||
| Net Income | -18.29M | -14.80M | -10.23M | -9.30M | -630.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -11.00 | -20.84 | -14.82 | -13.47 | -0.92 | |||
| Statistics | ||||||||
All data in USD